Chris Heberlig - Net Worth and Insider Trading

Chris Heberlig Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Chris Heberlig owns 2 companies in total, including Organovo Holdings Inc (ONVO) , and Kiniksa Pharmaceuticals International PLC (KNSA) .

Click here to see the complete history of Chris Heberlig’s form 4 insider trades.

Insider Ownership Summary of Chris Heberlig

Ticker	Comapny	Transaction Date	Type of Owner
ONVO	Organovo Holdings Inc	2020-09-15	President and CFO
KNSA	Kiniksa Pharmaceuticals International PLC	2018-05-23	10 percent owner & Exec VP & CFO

Chris Heberlig Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Chris Heberlig Ownership Network

Ownership Network List of Chris Heberlig

No Data

Ownership Network Relation of Chris Heberlig

Chris Heberlig Owned Company Details

What does Organovo Holdings Inc do?

Who are the key executives at Organovo Holdings Inc?

Chris Heberlig is the President and CFO of Organovo Holdings Inc. Other key executives at Organovo Holdings Inc include President & CFO and PFO Thomas Hess , General Counsel & Secretary Thomas E Jurgensen , and Chief Scientific Officer Jeffrey N. Miner .

Organovo Holdings Inc (ONVO) Insider Trades Summary

Over the past 18 months, Chris Heberlig made no insider transaction in Organovo Holdings Inc (ONVO). Other recent insider transactions involving Organovo Holdings Inc (ONVO) include a net sale of 19,607 shares made by David Gobel ,

In summary, during the past 3 months, insiders sold 0 shares of Organovo Holdings Inc (ONVO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,607 shares of Organovo Holdings Inc (ONVO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 19,607 shares.

Organovo Holdings Inc (ONVO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Organovo Holdings Inc Insider Transactions

No Available Data

Chris Heberlig Mailing Address

Above is the net worth, insider trading, and ownership report for Chris Heberlig. You might contact Chris Heberlig via mailing address: C/o Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton D0 Hm11.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.